1951:TSEJinxin Fertility Group Limited Analysis
Data as of 2026-03-14 - not real-time
HK$2.22
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Price dynamics: Jinxin Fertility trades at HK$2.22, barely above the calculated support of HK$2.21 and well under its 20‑day (HK$2.44) and 50‑day (HK$2.46) moving averages, signalling a bearish chart pattern. The RSI of 33.7 places the stock in oversold territory and the MACD remains bearish, yet volume is trending upward, hinting at possible accumulation at the floor.
Fundamental backdrop: The company is priced at a forward P/E of ~14 versus an industry average of ~26 and a P/B of 0.58, suggesting a valuation discount. Forward EPS is projected positive while trailing earnings are negative with a –35.6% profit margin and a high debt‑to‑equity of 31.6, creating balance‑sheet stress. Analysts (11) rate the stock “buy” with a median target of HK$3.58, implying roughly 53% upside. Low beta (0.27) combined with high 30‑day volatility (~35%) yields a mixed risk profile.
Fundamental backdrop: The company is priced at a forward P/E of ~14 versus an industry average of ~26 and a P/B of 0.58, suggesting a valuation discount. Forward EPS is projected positive while trailing earnings are negative with a –35.6% profit margin and a high debt‑to‑equity of 31.6, creating balance‑sheet stress. Analysts (11) rate the stock “buy” with a median target of HK$3.58, implying roughly 53% upside. Low beta (0.27) combined with high 30‑day volatility (~35%) yields a mixed risk profile.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price hovering just above technical support
- Oversold RSI indicating potential rebound
- Increasing volume suggesting accumulation
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio limiting near‑term earnings recovery
- Forward earnings projection positive but not yet realized
- Regulatory environment for assisted reproductive services
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Demographic tailwinds driving demand for fertility services
- Valuation discount relative to industry peers
- Low beta indicating limited systematic risk over a longer horizon
Key Metrics & Analysis
Financial Health
Revenue Growth-10.70%
Profit Margin-35.63%
P/E Ratio14.0
ROE-9.85%
ROA1.13%
Debt/Equity31.63
P/B Ratio0.6
Op. Cash FlowHK$513.3M
Free Cash FlowHK$8.0M
Industry P/E26.2
Technical Analysis
TrendBearish
RSI33.7
SupportHK$2.21
ResistanceHK$2.55
MA 20HK$2.44
MA 50HK$2.46
MA 200HK$2.71
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceHK$3.41
Upside/Downside53.49%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.27
Volatility34.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.